Prime Medicine PRME Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's operating lease liabilities (total)?
- Prime Medicine (PRME) reported operating lease liabilities (total) of $114.51M in Q1 2026.
- How has Prime Medicine's operating lease liabilities (total) changed year-over-year?
- Prime Medicine's operating lease liabilities (total) decreased by 5.5% year-over-year, from $121.15M to $114.51M.
- What is the long-term trend for Prime Medicine's operating lease liabilities (total)?
- Over 4 years (2020 to 2025), Prime Medicine's operating lease liabilities (total) has grown at a 156.3% compound annual growth rate (CAGR), from $2.7M to $116.43M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.